Why the study?
Does direct admission to the catheterization laboratory reduce mortality and shorten time-to-treatment intervals in patients with STEMI?
Does direct admission to the catheterization laboratory reduce mortality and shorten time-to-treatment intervals in patients with STEMI?
Direct admission to the cath lab for STEMI shortens both pain-to-balloon and door-to-balloon times, but only the reduction in pain-to-balloon time impacts mortality, highlighting the need for early EMS activation.
Answers are grounded in this paper and cite their sources.
May support prehospital activation to shorten pain-to-balloon time in STEMI; leaves open prospective validation before practice change.
<0.001). Conclusions Direct admission of PPCI-treated patients with STEMI decreased mortality by shortening P2B and D2B intervals considerably. However, P2B, but not D2B, impacted mortality. It seems that the D2B interval has reached its limit of effect. Thus, all efforts should be extended to shorten P2B by educating the public to activate early the emergency medical services to bypass the emergency department and allow timely PPCI for the best outcome.
No takes yet. Share an insight, caveat, or question.
Meisel et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: